During the past decade, Southern Cancer Center conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 30 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 19 clinical trials were completed. i.e. 146.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Cancer Center" #1 sponsor was "Bristol-Myers Squibb" with 10 trials, followed by "National Cancer Institute (NCI)" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator and "NSABP Foundation Inc" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Southern Cancer Center" are "Non-Small Cell Lung Cancer" (5 trials), "Metastatic Breast Cancer" (4 trials), "Multiple Myeloma" (4 trials), "Breast Cancer" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Southern Cancer Center" in a lesser frequency.

Most popular intervention types in "Southern Cancer Center" are "Drug" (58 trials), "Other" (15 trials), "Biological" (10 trials), "Procedure" (7 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (10 trials), "Placebo" (9 trials), "Laboratory Biomarker Analysis" (7 trials), "Paclitaxel" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Southern Cancer Center" are 56 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Southern Cancer Center". undefined are not yet recruiting, 8 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Southern Cancer Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Cancer Center, 4 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".